GGrantIndex
← Leaderboards

Charles Louis Edelstein

Va Eastern Colorado Health Care System

$4,308,015
Attributed
$4,308,015
Total exposure
5
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $908.1K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,308,015 · 3
VA$0 · 2

By mechanism

R01$4,308,015 · 2
I01$0 · 2
P01$0 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Proteins

Research focus

ProteinsCellsPublishingProtocols DocumentationApoptosisPlayKidneyIn VivoFutureRenal FunctionSignal TransductionLeadGrantInhibitor/AntagonistAttenuatedMediatingProductionCystPathway InteractionsGrowthTubular FormationProgramsKidney FailureAutosomal Dominant Polycystic Kidney

Grant awards (31)

mTORC1/2 Signaling in the Heart in Autosomal Dominant Polycystic Kidney Disease (ADPKD)$0
I01 · FY2025 · VA · contact PI
mTORC1/2 Signaling in the Heart in Autosomal Dominant Polycystic Kidney Disease (ADPKD)$0
I01 · FY2024 · VA · contact PI
mTORC1/2 Signaling in the Heart in Autosomal Dominant Polycystic Kidney Disease (ADPKD)$0
I01 · FY2023 · VA · contact PI
Autophagy in Polycystic Kidney Disease (PKD)$0
I01 · FY2021 · VA · contact PI
Autophagy in Polycystic Kidney Disease (PKD)$0
I01 · FY2020 · VA · contact PI
Autophagy in Polycystic Kidney Disease (PKD)$0
I01 · FY2019 · VA · contact PI
Autophagy in Polycystic Kidney Disease (PKD)$0
I01 · FY2018 · VA · contact PI
The IL-33/CD4 T cell/CXCL1 System in Acute Kidney Injury$0
I01 · FY2016 · VA · contact PI
The IL-33/CD4 T cell/CXCL1 System in Acute Kidney Injury$0
I01 · FY2015 · VA · contact PI
The IL-33/CD4 T cell/CXCL1 System in Acute Kidney Injury$0
I01 · FY2014 · VA · contact PI
The IL-33/CD4 T cell/CXCL1 System in Acute Kidney Injury$0
I01 · FY2013 · VA · contact PI
Mammalian target of rapamycin (mTOR) signaling in polycystic kidney disease (PKD)$290,469
R01 · FY2011 · DK · contact PI
Mammalian target of rapamycin (mTOR) signaling in polycystic kidney disease (PKD)$306,027
R01 · FY2010 · DK · contact PI
Caspase-1 signaling in ischemic acute renal failure$289,640
R01 · FY2010 · DK · contact PI
Caspase-1 signaling in ischemic acute renal failure$99,008
R01 · FY2010 · DK · contact PI
Mammalian target of rapamycin (mTOR) signaling in polycystic kidney disease (PKD)$382,282
R01 · FY2009 · DK · contact PI
Caspase-1 signaling in ischemic acute renal failure$292,566
R01 · FY2009 · DK · contact PI
Mammalian target of rapamycin (mTOR) signaling in polycystic kidney disease (PKD)$197,612
R01 · FY2009 · DK · contact PI
Mammalian target of rapamycin (mTOR) signaling in polycystic kidney disease (PKD)$35,670
R01 · FY2009 · DK · contact PI
Mammalian target of rapamycin (mTOR) signaling in polycystic kidney disease (PKD)$296,368
R01 · FY2008 · DK · contact PI
Caspase-1 and IL-18 in ischemic acute renal failure$292,566
R01 · FY2008 · DK · contact PI
Caspase-1 and IL-18 in ischemic acute renal failure$304,630
R01 · FY2007 · DK · contact PI
Mammalian target of rapamycin (mTOR) signaling in polycystic kidney disease (PKD)$302,416
R01 · FY2007 · DK · contact PI
ROLE OF CASPASES IN ISCHEMIC ACUTE RENAL FAILURE$227,978
R01 · FY2005 · DK
ROLE OF CASPASES IN ISCHEMIC ACUTE RENAL FAILURE$228,265
R01 · FY2004 · DK
ROLE OF CASPASES IN ISCHEMIC ACUTE RENAL FAILURE$228,544
R01 · FY2003 · DK
ROLE OF CASPASES IN ISCHEMIC ACUTE RENAL FAILURE$76,084
R01 · FY2003 · DK
ROLE OF CASPASES IN ISCHEMIC ACUTE RENAL FAILURE$228,814
R01 · FY2002 · DK
Caspases and Apoptosis in ADPKD$0
P01 · FY2002 · DK
ROLE OF CASPASES IN ISCHEMIC ACUTE RENAL FAILURE$229,076
R01 · FY2001 · DK
Caspases and Apoptosis in ADPKD$0
P01 · FY2001 · DK